Engineering Papers⌕ Search

SEARCH · Engineering Papers

Results for “MEDICAL PERSONNEL”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 199 records · Page 11
All sourcesNASA NTRSDOE OSTI
NASA NTRS1978

Emergency Communications Console

NASA has applied its communications equipment expertise to development of a communications console that provides, in a compact package only slightly larger than an electric typewriter, all the emergency medical services communications functions needed for a regional hospital. A prototype unit, built by Johnson Space Center, has been installed in the Odessa (Texas) Medical Center Hospital. The hospital is the medical control center for the 17-county Permian Basin Emergency Medical System in west Texas. The console project originated in response to a request to NASA from the Texas governor's office, which sought a better way of providing emergency medical care in rural areas. Because ambulance travel time is frequently long in remote areas of west Texas, it is important that treatment begin at the scene of the emergency rather than at the hospital emergency room. A radio and telephone system linking ambulance emergency technicians and hospital staff makes this possible. But earlier equipment was complex, requiring specialized operators. A highly reliable system was needed to minimize breakdowns and provide controls of utmost simplicity, so that the system could be operated by physicians and nurses rather than by communications specialists. The resulting console has both radio and telephone sections. With the radio equipment, hospital personnel can communicate with ambulance drivers and paramedics, receive incoming electrocardiagrams, consult with other hospitals, page hospital staff and set up a radio-to-telephone "patch." The telephone portion of the system includes a hotline from the Permian Basin Emergency Medical Service's resource control center, an automatic dialer for contacting special care facilities in the Permian Basin network, a hospital intercom terminal and a means of relaying cardioscope displays and other data between hospitals. The integrated system also provides links with local disaster and civil defense organizations and with emergency "Dial 911" control points.

Source record↗
NASA NTRS2007

Infrared Imaging Sharpens View in Critical Situations

Innovative Engineering and Consulting (IEC) Infrared Systems, a leading developer of thermal imaging systems and night vision equipment, received a Glenn Alliance for Technology Exchange (GATE) award, half of which was in the form of additional NASA assistance for new product development. IEC Infrared Systems worked with electrical and optical engineers from Glenn's Diagnostics and Data Systems Branch to develop a commercial infrared imaging system that could differentiate the intensity of heat sources better than other commercial systems. The research resulted in two major thermal imaging solutions: NightStalkIR and IntrudIR Alert. These systems are being used in the United States and abroad to help locate personnel stranded in emergency situations, defend soldiers on the battlefield abroad, and protect high-value facilities and operations. The company is also applying its advanced thermal imaging techniques to medical and pharmaceutical product development with a Cleveland-based pharmaceutical company.

Source record↗
NASA NTRS2006

Moving from Bilateral to Multilateral Medical Operations

When the ISS Integrated Medical Group moved to a multilateral configuration for the ASTROLAB mission, several challenges were encountered and overcome that allowed for a streamlined operational experience. Dating back to the early 1990s, the European Space Agency (ESA) has sent flight surgeon and Biomedical Engineering (BME) personnel to NASA-JSC and Russia to train for space flight operational support. This training was tailored towards the needs of particular Shuttle/Soyuz missions, and more generally for eventual ISS support. With the announcement of the ASTROLAB mission, NASA and ESA personnel worked together to develop a detailed training template for ESA BMEs to ensure successful support of the mission from the European Astronaut Center (EAC). This training included the deployment of ESA BMEs to JSC, as well as the development of a rotation of ISS-certified NASA BMEs to the EAC. In addition to training, NASA, ESA, and the Russian Federal Space Agency (FSA) worked together preflight to develop multilateral flight control support concepts and implementation plans. This resulted in flight control support schedules, operational rules of engagement, and the delineation of responsibilities. NASA also assisted ESA with the development and deployment of workstation displays to allow the ESA medical flight control team to monitor ISS telemetry from the EAC. The goal of this presentation is to provide details of the preflight preparation and in-flight support of the ASTROLAB mission by the ESA, NASA, and FSA medical support teams. In addition, it will identify lessons learned that will be implemented for future multilateral endeavors.

Roden, S.↗
DOE OSTI2020

Analysis of Exposure during Transportation of Waste to the Nevada National Security Site (NNSS) - 20445

Safety is a priority for the U.S. Department of Energy (DOE) Environmental Management (EM) Nevada Program. This commitment to safety is integrated into requirements and work procedures at DOE sites across the U.S. that generate low-level radioactive waste, mixed low-level radioactive waste, and classified waste that is transported to the Nevada National Security Site (NNSS) for permanent disposal. Generators of this waste are responsible for ensuring it is packaged and transported in a safe and compliant manner. These generators and their contracted commercial carriers must comply with U.S. Department of Transportation (DOT) regulations; the Nevada National Security Site Waste Acceptance Criteria (NNSSWAC); and other applicable federal, state, and local regulations and requirements. This includes packaging and shipping the waste to meet DOT regulatory radiation dose limits to ensure public safety during transportation. NNSS waste generators have a solid safety record for complying with these stringent regulations as demonstrated by the fact that no shipments exceeding DOT dose rate limits were received at the NNSS Area 5 Radioactive Waste Management Complex (RWMC) during FY 2014 through FY 2018. A 2005 study conducted by the Desert Research Institute validated shipments to the NNSS comply with DOT radiation dose limits. In response to recent Nevada stakeholder requests for an updated study, an analysis was conducted to verify and provide evidence that the public continues to be safe from exposure to radioactive waste shipment to the NNSS. Radiation exposure from radioactive waste shipments in transit to the NNSS was evaluated. Three studies were performed: 1. Confirm compliance of waste shipments to the DOT radiation limits using dose rate surveys taken at the generator site and at the disposal site. 2. Estimate the dose to the public from waste shipments using the dosimetry results for disposal site personnel by comparing time of exposure for various individuals/scenarios. 3. Estimate the truck driver dose using the receipt dose rate surveys and time of exposure, and from dosimetry results. Study 1 confirmed compliance with the DOT dose rate limits for a sample of waste shipments (123 of 1,038) received during fiscal year (FY) 2017. Study 2 showed that the average annual radiation equivalent dose for disposal site personnel during FY 2017 was approximately 6.7% [0.415 mSv (41.5 millirem)] of the annual average dose that a person living in the U.S. receives from all sources [6.2 mSv (620 mrem)]. Maximum dose to a member of the public, a person resting/sleeping in an adjacent truck at a rest area to a waste shipment, was 0.0166 mSv (1.66 mrem), which is less than the dose received from a person taking a round trip from the east coast to the west coast of the continental U.S. on an airplane [0.07 mSv (7 mrem) per round trip]. Study 3 showed that the truck driver who made the most shipments of radioactive waste to the NNSS, who drove the most hours (estimated time of exposure 2,520 hours), during FY 2017 had a total dose of 0.15 mSv (15 mrem), which was obtained from their personal dosimeter. The annual dose recorded for disposal site personnel, the dose estimates for the public, and the truck driver dose were all a small percentage of the average radiation dose a person receives from all sources (e.g., background and medical radiation). At these levels, risk should only be described qualitatively. Radiation exposure from radioactive waste shipments to the NNSS were shown to be compliant with the DOT dose rate limits, safe, and very low (i.e., within background levels). (authors)

12 MANAGEMENT OF RADIOACTIVE AND NON-RADIOACTIVE W↗
NASA NTRS1990

Postlanding optimum designs for the assured crew return vehicle

The optimized preliminary engineering design concepts for postlanding operations of a water-landing Assured Crew Return Vehicle (ACRV) during a medical rescue mission are presented. Two ACRVs will be permanently docked to Space Station Freedom, fulfilling NASA's commitment to Assured Crew Return Capability in the event of an accident or illness. The optimized configuration of the ACRV is based on an Apollo command module (ACM) derivative. The scenario assumes landing a sick or injured crewmember on water with the possibility of a delayed rescue. Design emphasis is placed on four major areas. First is the design of a mechanism that provides a safe and time-critical means of removing the sick or injured crewmember from the ACRV. Support to the assisting rescue personnel is also provided. Second is the design of a system that orients and stabilizes the craft after landing so as to cause no further injury or discomfort to the already ill or injured crewmember. Third is the design of a system that provides full medical support to a sick or injured crewmember aboard the ACRV from the time of separation from the space station to rescue by recovery forces. Last is the design of a system that provides for the comfort and safety of the entire crew after splashdown up to the point of rescue. The four systems are conceptually integrated into the ACRV.

Hosterman, Kenneth C.↗
NASA NTRS1969

Environmental health program in NASA

The NASA policy on environmental health uses medical and environmental concepts to: (1) Determine the health status of employees; (2) prevent illness and promote good health among employees; and (3) identify and control factors that affect the health of personnel and quality of environment. Evaluation and control of physical, chemical, radiological and biological factors surrounding personnel and which represent physiological and psychological stresses and impairment are considered.

Marrazzo, R. M.↗
NASA NTRS2003

The impact of the new biology on radiation risks in space

Radiation is considered to be one of three or four major hazards for personnel in space and has emerged as the most critical issue to be resolved for long-term missions, both orbital and interplanetary. Space habitats are stressful and dangerous environments. Health and medical consequences arising from microgravity, stress, and trauma include weakened immune systems, increased viral activity, and loss of bone mass. The greatest risks from radiation are generally assumed to be cancers and possibly damage to the central nervous system. Synergistic effects arising from the other environmental hazards along with abscopal and exogenic factors are likely. Space programs represent an exceptional opportunity for examining the biological consequences of low-dose exposures of humans to radiation at every level of progression. Although astronauts are a relatively small population, they are healthy, physically active volunteers who undergo extensive testing and medical examinations before, during, and after protracted exposures with periodic follow-up examinations. The radiation environments along with other hazards are likewise monitored and documented. Extensive international research programs are in progress. Seven years ago the U.S. National Aeronautics and Space Administration established the National Space Biomedical Research Institute through a cooperative agreement with a consortium of research and academic institutions in order to address radiation issues through a concerted, programmatic effort. Advanced technologies are rapidly being incorporated into these programs to determine the significance of new biological data and to evaluate the interplay among the different medical hazards. Programmatic in vivo and in vitro studies of the processes leading to carcinogenesis are in progress. Drugs and dietary supplements are being examined at the cellular and in vivo levels to assess their potential as dose-modifying agents. The infrastructure of this new approach, recent results, and research in progress are reviewed and discussed.

NASA Discipline Radiation Health↗
NASA NTRS1979

Medical Information Management System

On-line interactive information processing system easily and rapidly handles all aspects of data management related to patient care. General purpose system is flexible enough to be applied to other data management situations found in areas such as occupational safety data, judicial information, or personnel records.

Alterescu, S.↗
NASA NTRS2007

Pharmacotherapeutics of Intranasal Scopolamine: FDA Regulations and Procedures for Clinical Applications

Space Motion Sickness (SMS) is commonly experienced by astronauts and often requires treatment with medications during the early flight days of a space mission. Bioavailability of oral (PO) SMS medications is often low and highly variable; additionally, physiological changes in a microgravity environment exacerbate variability and decrease bioavailability. These factors prompted NASA to develop an intranasal dosage form of scopolamine (INSCOP) suitable for the treatment of SMS. However, to assure safety and efficacy of treatment in space, NASA physicians prescribe commercially available pharmaceutical products only. Development of a pharmaceutical preparation for clinical use must follow distinct clinical phases of testing, phase I through IV to be exact, before it can be approved by the FDA for approval for clinical use. After a physician sponsored Investigative New Drug (IND) application was approved by the FDA, a phase I clinical trial of INSCOP formulation was completed in normal human subjects and results published. The current project includes three phase II clinical protocols for the assessment of pharmacokinetics and pharmacodynamics (PK/PD), efficacy, and safety of INSCOP. Three clinical protocols that were submitted to FDA to accomplish the project objectives: 1) 002-A, a FDA Phase II dose ranging study with four dose levels between 0.1 and 0.4 mg in 12 subjects to assess PK/PD, 2) 002-B, a phase II clinical efficacy study in eighteen healthy subjects to compare efficacy of 0.2 (low dose) and 0.4 mg (high dose) INSCOP for prophylactic treatment of motion-induces (off-axis vertical rotation) symptoms, and (3) 002-C, a phase II clinical study with twelve subjects to determine bioavailability and pharmacodynamics of two doses (0.2 and 0.4 mg) of INSCOP in simulated microgravity, antiorthostatic bedrest. All regulatory procedures were competed that include certification for Good laboratory Procedures by Theradex , clinical documentation, personnel training, selection of clinical research operations contractor, data capturing and management, and annual reporting of results to FDA were successfully completed. Protocol 002-A was completed and sample and data analysis is currently in progress. Protocol 002-B is currently in progress at Dartmouth Hitchcock Medical Center and Protocol 002-C has been submitted to the FDA and will be implemented at the same contractor site as 002-A. An annual report was filed as required by FDA on the results of Protocol 002-A. Once all the three Phase II protocols are completed, a New Drug Administration application will be filed with FDA for Phase III clinical assessment and approval for marketing of the formulation. A commercial vendor will be identified for this phase. This is critical for making this available for treatment of SMS in astronauts and military personnel on duty. Once approved by FDA, INSCOP can be also used by civilian population for motion sickness associated with recreational travel and other ailments that require treatment with anticholinergic drugs.

Das, H.↗
NASA NTRSDate not supplied

A physician’s working group guides COVID-19 prevention in a mission critical environment

Background A team was assembled at the National Aeronautics and Space Administration’s (NASA) Johnson Space Center (JSC) to help navigate the shifting COVID-19 pandemic. Their goal was to mitigate the impact of COVID on astronauts, other essential personnel, and the human spaceflight program. This team supplemented the JSC Pandemic Incident Response Group, whose function is to set policy for the overall management of JSC’s COVID-19 mitigations for all onsite mission-essential and mission-critical activities, including health policy. Context The first mission to return to Earth from the International Space Station at the start of the pandemic returned when there was limited information about the transmission and prevention of COVID-19. The medical leadership at JSC determined that a dedicated team was required to navigate the uncharted waters of the pandemic. Description of Activities Issues tackled by this panel included: prevention of COVID-19 transmission during altitude, dive, and spacecraft training – activities that require prolonged close contact between multiple individuals who often cannot safely wear face masks; mitigating the risks of domestic and international travel for essential personnel; securing COVID-19 testing from local and foreign hospital systems; acquiring antigen and PCR analyzers for in-house testing; and the development of quarantine policies for crewed spacecraft launches and landings in Kazakhstan and the United States. The panel also provides clinical return-to-work guidance for cases of COVID-19 in essential personnel.

covid↗
NASA NTRS1969

Apollo 11 impact on the occupational medicine program, NASA Manned Spacecraft Center

Requirements and development of standards for occupational medicine support of personnel in the Lunar Receiving Laboratory (LRL) are outlined. Considered are proper personnel performance and exclusion of people prone to develop a serious illness within the quarantine area. Occupational medicine report for the LRL consists of examination procedures covering laboratory work, periodic examinations, immunizations, health maintenance, preventive practices, medical standards, and waiver authority.

Wright, P. E.↗
DOE OSTI2020

Los Alamos National Laboratory Release of Cesium-137 Corrective Action Plan

This Corrective Action Plan (CAP) was developed by a team chartered by John Sarrao, Deputy Director for Science, Technology, and Engineering (DDSTE), to review and respond to the findings of the Joint National Nuclear Security Administration/Triad National Security (NNSA/Triad) Investigation Team (JIT) Joint Investigation Report for the “Sealed Source Recovery at the University of Washington Harborview Training and Research Facility Results in Release of Cesium-137 on May 2, 2019,” dated March 30, 2020. On May 2, 2019, International Isotopes, Inc. (INIS), a subcontractor to Triad National Security, LLC, inadvertently breached a sealed cesium-137 source at the University of Washington (UW), Harborview Medical Center Research and Training (HRT) building in downtown Seattle while attempting to recover the source for the National Nuclear Security Administration (NNSA) Off-Site Source Recovery Program (OSRP). The source breach resulted in contamination of personnel and the HRT building, as well as a release of radioactive material to the environment

07 ISOTOPE AND RADIATION SOURCES↗
NASA NTRSDate not supplied

Watching Without Seeing a Tool to Surveil Astronaut Health Outcomes While Maintaining Astronaut Medical Privacy

BACKGROUND The Privacy Act of 1974 regulates the use a nd disclosure of personally identifiable information by US Federal agencies. The Act applies to biographical, financial, a nd other identity-linked information, a s well a s personal health information (PHI). As such, the use of astronaut PHI is limited to authorized personnel for preapproved uses, with data reporting often limited to aggregated information about groups. These limitations on the use a nd reporting of astronaut PHI complicates surveillance efforts, wherein epidemiologists a t the National Aeronautics and Space Administration (NASA)monitor the incidence of targeted health conditions in the astronaut population, or to discover emerging trends of aging and disease. Stratification on one or more covariates –particularly time-period, sex, a nd mission participation –can lead to extremely small datasets such that the reporting of results is potentially attributable to individuals. An additional challenge is the small size of the astronaut population, both in terms of numbers of individuals a s well a s in terms of density of exposure time. Such small datasets yield volatile rate estimates that are difficult to interpret. To a id the epidemiological surveillance efforts, a surveillance tool is required that can (a) satisfy the need for rapid computation of condition-specific incidence and mortality rates; (b) improve the statistical estimates of these estimated rates; and (c) maintain astronaut privacy. Here we describe a nd demonstrate such a tool. METHODS We devised a system that models incidence a nd mortality rates rather than calculating them directly. This ha s the advantage of using all the available data to derive the estimates, lea ding to rates that a re not attributable to any one individual, a nd a re a s numerically stable a s they can be given the extremely limited data. The system models disease endpoints using a Poisson regression model with exposure density (measured in person-years) a s a n offset term. By doing so the model is estimating event counts per person-year, equivalent to modeling the rates directly. It uses a standard (pre-specified)set of covariates; the system does not engage in “model-building” as model parsimony is not the goa l. Instead, it is explicitly recognized that if a covariate is not statistically significant a nd not a confounder then it will likely have very little effect on the estimate of the incidence a nd mortality rates. Users are able to specify the disease endpoint of interest and the covariates over which they would like to stratify. The system then uses the resulting model to compute the estimated rates for the user-chosen configuration of variables as visualizes those either over an age range within a specified time-period, or over time for astronauts with a specified age range. RESULTS The first iteration of the tool computes incidence a nd mortality rates for cardiovascular conditions and cancers. Code ha s been developed to retrieve the appropriate data from the IMPALA analysis platform, compute the models for incidence a nd mortality, a nd then use those models to generate the corresponding rate curves. A companion graphical user interface allows the user to specify the curves and visualize the results. CONCLUSIONS It is important to note that the rapid surveillance tool described here is neither meant to be a definitive assessment of the incidence or mortality of any particular disease or condition in the astronaut population, nor is it meant to be used for research purposes. Rather, it is meant as an early indicator that in-depth investigation may be warranted. By automating a repetitive process and leveraging carefully curated astronaut health outcomes, the tool makes possible a rapid “first look” into known areas of concern, and, if used judiciously, may surface new areas of concern for long-term astronaut health. This work is supported in part by the Translational Research Institute for Space Health (TRISH) through NASA Cooperative Agreement NNX16AO69A.

R J Reynolds↗
NASA NTRS1969

Experience factors in performing periodic physical evaluations

The lack of scientific basis in the so-called periodic health examinations on military personnel inclusive of the Executive Health Program is outlined. This latter program can well represent a management tool of the company involved in addition to being a status symbol. A multiphasic screening technique is proposed in conjunction with an automated medical history questionnaire for preventive occupational medicine methodology. The need to collate early sickness consultation or clinic visit histories with screening techniques is emphasized.

Hoffman, A. A.↗
NASA NTRS2017

One Giant Leap to Protect All Mankind: An Overview of the Lunar Receiving Laboratory

Motivation. In 1961, President John F. Kennedy charged the nation "to land a man on the moon and return him safely to Earth." Eight years later, the Apollo 11 astronauts splashed down in the Pacific Ocean after this first 8-day journey to the moon. As humans had never ventured to another extraterrestrial body, the U.S. government noted the great uncertainty associated with the unknown exposures related to this historic mission. Overview. With this uncertainty in mind, a newly formed Interagency Committee on Back Contamination (ICBC) was established to review the potential for lunar contaminants and establish the prevention of their escape into the biosphere during crew and sample recovery operations from the floating command module to the mobile quarantine facility on the recovery ship and return to the Johnson Space Center. Significance. As a result of the ICBC recommendations, in 1966 NASA planned and built the Lunar Receiving Laboratory (LRL) at the Johnson Space Center in Houston, Texas. The LRL served a great role in service of human space exploration to quarantine Apollo crewmembers, their space vehicles, and the lunar samples collected. Almost an afterthought in the space race to the Moon, the 83,000-square-foot LRL was designed and completed in 1967 for $7.8 million. The core purpose of the LRL was "to protect the public's health, agriculture, and other living resources; to provide lunar sample distribution to approved scientific investigators; and to preserve the scientific integrity of the lunar samples at all times." Its layout was comprised of three major zones: a quarantined Crew Area, a separate but also quarantined Sample Operations Area, and a Support and Administration Area outside the controlled biological barrier. This facility required trained personnel to live and perform within it for several weeks post-flight, to include astronaut crewmembers, flight surgeons, scientists, and vehicle recovery engineers. The LRL holds memories of these historic events but has since been repurposed for NASA's medical and environmental sciences activities, in what is now known as Building 37. As we approach its 50th anniversary, the LRL story will end in demolition as NASA advances its facilities for the next steps in human exploration of space. Learning Objectives: 1. To capture the historical relevance of the NASA Lunar Receiving Laboratory 2. To understand the requirements of receiving crew and samples from the moon for the first time 3. To describe the facility capabilities in protection of public health.

Hayes, Judith↗
NASA NTRSDate not supplied

Ongoing Work: A Prototype Dataset for Low-flying Autonomous Medical UAS Operations

This paper presents ongoing work to create a dataset for low-flying autonomous medical UAS operations, focused on human stance recognition. This is an exploration of the viability of airborne classification for the Drone as a First Responder (DFR) concept in which a UAS arrives at the scene of an incident before emergency response personnel can get there and provides some level of situational awareness for the personnel arriving to the scene. Future incarnations could also see the UAS administer some level of care to injured parties at the scene. The data set, focused on detecting human stance, being developed here is the result of 30 test flights at NASA Langley Research Center in early 2024. In addition to flights where the participant (an anthropomorphic testing device or human) is alone in the viewing area holding a particular stance, two emergency scenes have been fabricated and collected through video - ``bike crash'' and ``difficult camping''. These test flights include four human participants. The contribution of this work upon completion will be a publicly available data set for the development of classification engines focused on human stance, and in the future, even triage.

Uncrewed Aerial Systems↗
NASA NTRS2019

Safety of Spaceflight Participants Aboard Suborbital Reusable Launch Vehicles

The anticipated advent of the U.S. Government sponsoring human-tended research on commercial suborbital flights necessitates the establishment of safety review procedures for federal agencies to allow government-sponsored spaceflight participants (SFPs) aboard these vehicles. Safety practices for National Aeronautics & Space Administration (NASA) personnel aboard aircraft, orbital rockets and platforms, and a non- NASA vehicle, the Soyuz, are summarized. The valuable “Recommended Practices for Human Space Flight Occupant Safety,” published by the FAA Office of Commercial Space Transportation (FAA-AST) in 2014, are summarized. Medical recommendations for operationally critical flight crewmembers, published by the Aerospace Medical Association Commercial Spaceflight Working Group, are reviewed. FAA-AST approved SFP training available at three U.S. commercial companies is summarized. Activities of ASTM International Committee F47 on Commercial Spaceflight, formed in 2016, are reviewed. Finally, safety comparisons are made with another challenging environment, deep sea submersibles.

space transportation↗
NASA NTRS2010

Telescience Support Center Data System Software

The Telescience Support Center (TSC) team has developed a databasedriven, increment-specific Data Require - ment Document (DRD) generation tool that automates much of the work required for generating and formatting the DRD. It creates a database to load the required changes to configure the TSC data system, thus eliminating a substantial amount of labor in database entry and formatting. The TSC database contains the TSC systems configuration, along with the experimental data, in which human physiological data must be de-commutated in real time. The data for each experiment also must be cataloged and archived for future retrieval. TSC software provides tools and resources for ground operation and data distribution to remote users consisting of PIs (principal investigators), bio-medical engineers, scientists, engineers, payload specialists, and computer scientists. Operations support is provided for computer systems access, detailed networking, and mathematical and computational problems of the International Space Station telemetry data. User training is provided for on-site staff and biomedical researchers and other remote personnel in the usage of the space-bound services via the Internet, which enables significant resource savings for the physical facility along with the time savings versus traveling to NASA sites. The software used in support of the TSC could easily be adapted to other Control Center applications. This would include not only other NASA payload monitoring facilities, but also other types of control activities, such as monitoring and control of the electric grid, chemical, or nuclear plant processes, air traffic control, and the like.

Rahman, Hasan↗